Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLIS3 antisense RNA 1 (GLIS3-AS1) is a long non-protein coding RNA that acts in an antisense orientation to the GLIS3 gene. It is known to interact with the promoter region of GLIS3 and may negatively regulate GLIS3 gene expression by interfering with transcription. Such antisense RNAs generally modulate gene expression through mechanisms like promoter competition, transcriptional interference, or chromatin modification, impacting their corresponding sense genes’ transcription and cellular functions. GLIS3-AS1 has aliases including C9orf70 and MGC16153, and is registered under NCBI Gene ID 84850 and Ensembl ENSG00000237009.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GLIS3 antisense RNA 1 (GLIS3-AS1).